PFE:NYE-Pfizer Inc.

EQUITY | Drug Manufacturers | New York Stock Exchange

Last Closing Price

USD 43.92

Change

0.00 (0.00)%

Market Cap

USD 253.88B

Volume

0.03B

Average Target Price

USD 43.24 (-1.54%)
Average Analyst Rating

Verdict

STA Verdict

Verdict

About

Pfizer Inc is a research-based biopharmaceutical company. The Company's portfolio includes medicines, vaccines and medical devices, as well as many of the consumer healthcare products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2018-12-09 )

Largest Industry Peers for Drug Manufacturers

Symbol Name Price(Change) Market Cap
JNJ Johnson & Johnson

N/A

USD 390.04B
NVS Novartis AG

N/A

USD 201.15B
MRK Merck & Company Inc. (new)

N/A

USD 199.50B
ABBV AbbVie Inc.

N/A

USD 130.81B
LLY Eli Lilly and Company

N/A

USD 120.32B
SNY Sanofi American Depositary Sha..

N/A

USD 108.28B
AZN Astrazeneca PLC

N/A

USD 96.73B
GSK GlaxoSmithKline PLC

N/A

USD 92.53B
BMY Bristol-Myers Squibb Company

N/A

USD 86.64B
AGN Allergan plc

N/A

USD 51.41B

ETFs Containing PFE

FTXH First Trust Nasdaq Pharma.. 12.05 % 0.60 %

N/A

USD 4.19M
IHE iShares U.S. Pharmaceutic.. 10.13 % 0.43 %

N/A

USD 0.40B
GNRX Market Vectors Generic Dr.. 8.66 % 0.57 %

N/A

USD 3.65M
XLV SPDR Select Sector Fund -.. 7.32 % 0.14 %

N/A

USD 19.01B
IYH iShares U.S. Healthcare 6.94 % 0.43 %

N/A

USD 2.45B
FHLC Fidelity MSCI Health Care.. 6.29 % 0.08 %

N/A

USD 1.61B
VHT Vanguard Health Care 6.28 % 0.10 %

N/A

USD 8.82B
XHD:CA iShares U.S. High Dividen.. 6.20 % 0.33 %

N/A

CAD 0.20B
HDV iShares Core High Dividen.. 6.20 % 0.08 %

N/A

USD 6.57B
XHU:CA iShares U.S. High Dividen.. 6.19 % 0.32 %

N/A

CAD 0.03B
RXL ProShares Ultra Health Ca.. 5.86 % 0.95 %

N/A

USD 0.14B
PJP Invesco Dynamic Pharmaceu.. 5.81 % 0.57 %

N/A

USD 0.51B
JHMH John Hancock Multifactor .. 5.61 % 0.50 %

N/A

USD 0.06B
PPH VanEck Vectors Pharmaceut.. 5.48 % 0.35 %

N/A

USD 0.26B
FDL First Trust Morningstar 5.42 % 0.45 %

N/A

USD 1.46B
HHL:CA Harvest Healthcare Leader.. 5.21 % 1.24 %

N/A

CAD 0.28B
HHL.U:CA Harvest Healthcare Leader.. 5.21 % 0.00 %

N/A

CAD 0.03B
IXJ iShares Global Healthcare 5.21 % 0.47 %

N/A

USD 1.74B
SCHD Schwab US Dividend Equity 5.04 % 0.07 %

N/A

USD 7.93B
SDGA Impact Shares Sustainable.. 4.98 % 0.00 %

N/A

N/A
XPH SPDR S&P Pharmaceuticals 4.82 % 0.35 %

N/A

USD 0.29B
DJD Invesco Dow Jones Industr.. 4.68 % 0.30 %

N/A

USD 0.05B
PILL Direxion Daily Pharmaceut.. 4.36 % 0.00 %

N/A

USD 4.01M
ZVU:CA BMO MSCI USA Value Index .. 4.10 % 0.34 %

N/A

CAD 8.45M
ZWH.U:CA BMO US High Dividend Cove.. 4.08 % 0.72 %

N/A

CAD 0.06B
ZWH:CA BMO US High Dividend Cove.. 4.08 % 0.71 %

N/A

CAD 0.67B
VLUE iShares Edge MSCI USA Val.. 4.07 % 0.15 %

N/A

USD 2.42B
JKF iShares Morningstar Large.. 4.04 % 0.25 %

N/A

USD 0.39B
XDU:CA iShares Core MSCI US Qual.. 3.98 % 0.16 %

N/A

CAD 0.03B
MTUM iShares Edge MSCI USA Mom.. 3.94 % 0.15 %

N/A

USD 3.60B
HID.B:CA WisdomTree U.S. High Divi.. 3.65 % 0.37 %

N/A

CAD 0.01B
HID:CA WisdomTree U.S. High Divi.. 3.65 % 0.41 %

N/A

CAD 0.01B
DHS WisdomTree U.S. High Divi.. 3.64 % 0.38 %

N/A

USD 0.89B
VSMV VictoryShares US Multi-Fa.. 3.09 % 0.35 %

N/A

N/A
USMC Principal U.S. Mega-Cap M.. 3.06 % 0.12 %

N/A

USD 1.50B
DGRO iShares Core Dividend Gro.. 3.01 % 0.08 %

N/A

USD 4.97B
XDG:CA iShares Core MSCI Global .. 2.99 % 0.22 %

N/A

CAD 0.07B
IWX iShares Russell Top 200 V.. 2.97 % 0.20 %

N/A

USD 0.38B
MOAT VanEck Vectors Morningsta.. 2.94 % 0.48 %

N/A

USD 1.69B
OUSA O'Shares FTSE U.S. Qualit.. 2.91 % 0.48 %

N/A

USD 0.58B
LVHD Legg Mason Low Volatility.. 2.87 % 0.29 %

N/A

USD 0.63B
SHU:CA Sphere FTSE US Sustainabl.. 2.83 % 0.70 %

N/A

CAD 3.41M
FBU:CA First Asset U.S. Buyback .. 2.66 % 0.80 %

N/A

CAD 0.04B
WEXP WisdomTree U.S. Export an.. 2.66 % 0.33 %

N/A

USD 0.81M
VYM Vanguard High Dividend Yi.. 2.53 % 0.08 %

N/A

USD 21.17B
LVL Invesco S&P Global Divide.. 2.51 % 0.64 %

N/A

USD 0.03B
DIV Global X Super Dividend 2.41 % 0.45 %

N/A

USD 0.27B
MGV Vanguard Mega Cap Value 2.37 % 0.07 %

N/A

USD 2.11B
SPDV AAM S&P 500 High Dividend.. 2.35 % 0.00 %

N/A

USD 0.02B
SDOG ALPS Sector Dividend Dogs 2.34 % 0.40 %

N/A

USD 2.08B
SCHV Schwab U.S. Large-Cap Val.. 2.34 % 0.04 %

N/A

USD 4.74B
FDRR Fidelity Dividend ETF for.. 2.33 % 0.29 %

N/A

USD 0.40B
DLN WisdomTree U.S. LargeCap .. 2.31 % 0.28 %

N/A

USD 1.91B
IOO iShares Global 100 2.25 % 0.40 %

N/A

USD 1.83B
RNDV First Trust US Equity Div.. 2.18 % 0.50 %

N/A

USD 5.15M
QDF FlexShares Quality Divide.. 2.16 % 0.37 %

N/A

USD 1.70B
ESG FlexShares STOXX US ESG I.. 2.10 % 0.32 %

N/A

USD 0.03B
WOMN Impact Shares Trust I ETF.. 2.10 % 0.00 %

N/A

N/A
AUSF Global X Funds Adaptive U.. 2.09 % 0.00 %

N/A

USD 0.08B
IWD iShares Russell 1000 Valu.. 2.02 % 0.20 %

N/A

USD 37.92B
VTV Vanguard Value 2.02 % 0.05 %

N/A

USD 42.52B
QDEF FlexShares Quality Divide.. 2.00 % 0.37 %

N/A

USD 0.33B
FVAL Fidelity Value Factor 1.97 % 0.29 %

N/A

USD 0.10B
NACP Impact Shares Trust I NAA.. 1.96 % 0.00 %

N/A

N/A
CLRG IQ Chaikin U.S. Large Cap.. 1.95 % 0.25 %

N/A

USD 0.38B
JVAL JPMorgan U.S. Value Facto.. 1.95 % 0.00 %

N/A

N/A
DTD WisdomTree U.S. Total Div.. 1.94 % 0.28 %

N/A

USD 0.60B
VONV Vanguard Russell 1000 Val.. 1.93 % 0.12 %

N/A

USD 1.67B
FQAL Fidelity Quality Factor 1.89 % 0.29 %

N/A

USD 0.12B
FDLO Fidelity Low Volatility F.. 1.87 % 0.29 %

N/A

USD 0.09B
PUD:CA Purpose US Dividend Fund 1.86 % 0.68 %

N/A

CAD 0.02B
PUD.B:CA Purpose US Dividend Fund 1.86 % 0.69 %

N/A

CAD 7.18M
JQUA JPMorgan U.S. Quality Fac.. 1.84 % 0.00 %

N/A

N/A
DEW WisdomTree Global High Di.. 1.82 % 0.58 %

N/A

USD 0.09B
PDF:CA Purpose Core Dividend Fun.. 1.80 % 0.68 %

N/A

CAD 0.32B
ZDY:CA BMO US Dividend ETF 1.73 % 0.34 %

N/A

CAD 1.46B
ZDY.U:CA BMO US Dividend ETF 1.73 % 0.33 %

N/A

CAD 0.04B
ZUH:CA BMO Equal Weight US Healt.. 1.71 % 0.39 %

N/A

CAD 0.39B
PDIV:CA Purpose Enhanced Dividend.. 1.69 % 0.00 %

N/A

CAD 0.01B
RUD.U:CA RBC Quant U.S. Dividend L.. 1.66 % 0.43 %

N/A

CAD 0.03B
RUD:CA RBC Quant U.S. Dividend L.. 1.66 % 0.43 %

N/A

CAD 0.39B
FCRR:CA Fidelity U.S. Dividend fo.. 1.60 % 0.00 %

N/A

CAD 0.06B
DTN WisdomTree U.S. Dividend .. 1.59 % 0.38 %

N/A

USD 0.77B
USMV iShares Edge MSCI Min Vol.. 1.59 % 0.15 %

N/A

USD 13.46B
XMU:CA iShares Edge MSCI Min Vol.. 1.58 % 0.33 %

N/A

CAD 0.26B
DRMU:CA Desjardins RI USA - Low C.. 1.57 % 0.00 %

N/A

CAD 5.85M
SPYD SPDR Series Trust Portfol.. 1.54 % 0.12 %

N/A

USD 0.85B
CDC Compass EMP US EQIncome 1.. 1.51 % 0.35 %

N/A

USD 0.03B
CDL Compass EMP US Large Cap .. 1.50 % 0.35 %

N/A

N/A
FNDX Schwab Fundamental U.S. L.. 1.50 % 0.25 %

N/A

USD 4.45B
PRID InsightShares LGBT Employ.. 1.48 % 0.00 %

N/A

N/A
SPXT ProShares S&P 500 Ex-Tech.. 1.45 % 0.27 %

N/A

USD 2.53M
MMTM SPDR S&P 1500 Momentum Ti.. 1.44 % 0.12 %

N/A

USD 0.04B
SPXN ProShares S&P 500 Ex-Fina.. 1.39 % 0.27 %

N/A

USD 1.39M
IUS Invesco Strategic US ETF 1.39 % 0.00 %

N/A

USD 2.35M
FNDB Schwab Fundamental U.S. B.. 1.38 % 0.25 %

N/A

USD 0.26B
FLQG Franklin LibertyQ Global .. 1.25 % 0.35 %

N/A

USD 0.02B
XRLV Invesco S&P 500 ex-Rate S.. 1.21 % 0.25 %

N/A

USD 0.14B
PSET Principal Price Setters I.. 1.20 % 0.29 %

N/A

USD 0.02B
FLUS:CA Franklin LibertyQT U.S. E.. 1.18 % 0.28 %

N/A

CAD 0.28B
CHGX Change Finance U.S. Large.. 1.17 % 0.64 %

N/A

USD 3.83M
ESGG FlexShares STOXX Global E.. 1.03 % 0.42 %

N/A

USD 0.08B
TILT FlexShares Mornigstar US .. 0.99 % 0.25 %

N/A

USD 1.32B
JDIV JPMorgan U.S. Dividend 0.67 % 0.00 %

N/A

N/A
LOWC SPDR MSCI ACWI Low Carbon.. 0.65 % 0.20 %

N/A

USD 0.14B
JMIN JPMorgan U.S. Minimum Vol.. 0.64 % 0.00 %

N/A

N/A
CRBN iShares MSCI ACWI Low Car.. 0.61 % 0.20 %

N/A

USD 0.50B
CHEP AGFiQ U.S. Market Neutral.. 0.54 % 1.12 %

N/A

USD 1.10M
JPUS JPMorgan Diversified Retu.. 0.47 % 0.21 %

N/A

N/A
JPGE JPMorgan Diversified Retu.. 0.35 % 0.38 %

N/A

USD 0.06B
CFO VictoryShares US 500 Enha.. 0.35 % 0.35 %

N/A

USD 0.03B
CFA Compass EMP U.S. 500 Vola.. 0.35 % 0.35 %

N/A

USD 9.33M

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers)
Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.26% 85% B 94% A
Dividend Return 3.75% 82% B- 64% D
Total Return 25.01% 90% A- 95% A
Trailing 12 Months  
Capital Gain 22.89% 90% A- 95% A
Dividend Return 3.81% 82% B- 62% D-
Total Return 26.69% 90% A- 95% A
Trailing 5 Years  
Capital Gain 39.08% 72% C- 79% C+
Dividend Return 19.00% 73% C 60% D-
Total Return 58.07% 67% D+ 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 6.73% 75% C 69% D+
Dividend Return 10.40% 75% C 73% C
Total Return 3.67% 80% B- 64% D
Risk Return Profile  
Volatility (Standard Deviation) 9.78% 95% A 68% D+
Risk Adjusted Return 106.30% 95% A 85% B
Market Capitalization 188.79B 96% A 100% A+

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers)
Ratio vs. Market
(New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 10.93 72% C- 54% F
Price/Book Ratio 3.69 38% F 19% F
Price / Cash Flow Ratio 3.70 42% F 32% F
Price/Free Cash Flow Ratio 16.57 48% F 35% F
Management Effectiveness  
Return on Equity 33.72% 88% B+ 91% A-
Return on Invested Capital 13.92% 64% D 69% D+
Return on Assets 14.24% 96% A 94% A
Debt to Equity Ratio 61.25% 50% F 56% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Higly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector